Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Brian Druker, Nicholas B. Lydon

Research output: Contribution to journalArticle

764 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)3-7
Number of pages5
JournalJournal of Clinical Investigation
Volume105
Issue number1
StatePublished - Jan 2000

Fingerprint

Proto-Oncogene Proteins c-abl
Piperazines
Pyrimidines
Drug Design
Enzyme Inhibitors
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Antineoplastic Agents
Protein-Tyrosine Kinases
Binding Sites

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia. / Druker, Brian; Lydon, Nicholas B.

In: Journal of Clinical Investigation, Vol. 105, No. 1, 01.2000, p. 3-7.

Research output: Contribution to journalArticle

@article{6515ab3e0f7849b59462b87049a6fa99,
title = "Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia",
author = "Brian Druker and Lydon, {Nicholas B.}",
year = "2000",
month = "1",
language = "English (US)",
volume = "105",
pages = "3--7",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

AU - Druker, Brian

AU - Lydon, Nicholas B.

PY - 2000/1

Y1 - 2000/1

UR - http://www.scopus.com/inward/record.url?scp=0033987746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033987746&partnerID=8YFLogxK

M3 - Article

C2 - 10619854

AN - SCOPUS:0033987746

VL - 105

SP - 3

EP - 7

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -